AWA
LJPC

Amplius Wealth Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Amplius Wealth Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,255
Closed -$5K – 1025
2021
Q4 		$5K Buy
+1,255
New +$5.23K ﹤0.01% 726

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Amplius Wealth Advisors's LJPC Position: Q1 2022 in Review

Amplius Wealth Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2022, closing a stake of 1,255 shares — an estimated $5K sold.

Amplius Wealth Advisors first reported a position in LJPC in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 45 funds tracked by Wall St. Rank hold LJPC as of Q1 2022.

  • Amplius Wealth Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q1 2022 after selling out during the quarter.
  • Amplius Wealth Advisors sold 1,255 La Jolla Pharmaceutical Company shares in Q1 2022, an estimated $5K.
  • Amplius Wealth Advisors first reported a position in La Jolla Pharmaceutical Company in Q4 2021 and held it in 1 quarter.
  • Amplius Wealth Advisors's La Jolla Pharmaceutical Company position peaked at $5K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2022.

Based on Amplius Wealth Advisors's 13F filing for Q1 2022, filed 9 May 2022.